The administration of the grapefruit flavonoid naringenin is an example of how a drug which acts on astrocytes [82] can produce a moderate but persistent increase in the expression of GDNF and BDNF [83,84], thus protecting DA-cells in PD models [85,86]. The gene discussed is BDNF; the disease is Parkinson disease.